Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ergomax is a Netherlands-based company specializing in the development and distribution of high-quality nutraceuticals and biohacking supplements. The company focuses on providing natural, effective solutions for optimal health, including specialized products like bovine organ extracts, collagen, and mitochondrial support formulas. Ergomax emphasizes transparency and scientific backing for its curated selection of third-party and proprietary brands. Their business model primarily revolves around e-commerce, serving a global customer base interested in longevity and performance optimization. Key product categories include gut health, brain health, and energy metabolism, often utilizing unique ingredients like palmitoylethanolamide. The company is recognized in the European market as a leader in the biohacking community, offering education alongside their product offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ergomax.